TP53 and neoplasm: Mismatch-repair deficiency (MMR) leads the inactivation of some anti-tumour factors [107, 108] such as transforming growth factor β (TGF-β) receptor type II (TGFBR2) [109], BCL2-associated X protein (BAX), Caspase-5 and TP53 [110–113].